<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02723188</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-13-TH-334</org_study_id>
    <nct_id>NCT02723188</nct_id>
  </id_info>
  <brief_title>Modulation of Fear Extinction Processes Using Transcranial Electrical Stimulation</brief_title>
  <official_title>Modulation of Fear Extinction Processes Using Transcranial Electrical Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel Aviv University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel Aviv University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine the effects of transcranial electrical stimulation on
      processes associated with fear extinction in healthy humans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research links the processes of fear conditioning and extinction to the treatment of anxiety
      and stress-related disorders. Moreover, considerable translational research examines the
      neural correlates of these processes. However, virtually no research in humans manipulates
      neural correlates of these processes, which limits basic-clinical integration. The present
      study aimed to use transcranial electrical stimulation (tES) to modulate processes associated
      with fear extinction in order to assess the potential utility of tES in enhancing
      exposure-based treatment. To this end, healthy participants underwent a three-day fear
      conditioning and extinction paradigm. Participants were randomly assigned into 3 groups,
      differing in terms of tES applied during the extinction learning phase (Day 2) and targeting
      the medial prefrontal cortex: 1) direct current (DC) stimulation, aimed at enhancing
      extinction learning; 2) alternate current (AC) stimulation, aimed at interfering with
      reconsolidation of the fear memory activated during the extinction phase; and 3) sham
      stimulation. The outcome measures (outlined next) involve the assessment of extinction recall
      during a test phase (Day 3). Successful modulation of extinction learning by tES would be
      reflected in enhanced extinction recall.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Galvanic Skin Response (GSR)</measure>
    <time_frame>During three-day experimental task</time_frame>
    <description>GSR was measured throughout the task using 2 standard electrodes on the fingers. Measurement units were in micro-Siemens; scores were square-root-transformed (a common method in GSR studies). A higher level of GSR in response to stimuli is taken to reflect greater physiological fear response, and thus worse in the context of the relevance of the study conditions to the treatment of anxiety disorders.
Scores were collected in response to presentation of the CS+ (the stimulus conditioned to be associated with an aversive outcome) and the CS- (the stimulus not conditioned to be associated with any outcome).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported Fear Rankings</measure>
    <time_frame>During three-day experimental task</time_frame>
    <description>Participants marked how fearful they are of stimuli used in the task on a single 10-point scale (1=not afraid, 10=extremely afraid). Higher scores therefore reflect greater fear and are worse in the context of treatment for anxiety disorders.
Scores were collected in response to presentation of the CS+ (the stimulus conditioned to be associated with an aversive outcome) and the CS- (the stimulus not conditioned to be associated with any outcome).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Stress Related Disorder</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham electrical stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DC: Direct current</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Direct current electrical stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AC: Alternating current</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alternating current electrical stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham stimulation (1.5 milliampere,30 seconds)</intervention_name>
    <arm_group_label>Sham</arm_group_label>
    <other_name>DC Stimulator Plus (neuroConn, Germany), serial 0118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC stimulation (1.5 milliampere, 20 minutes)</intervention_name>
    <arm_group_label>DC: Direct current</arm_group_label>
    <other_name>DC Stimulator Plus (neuroConn, Germany), serial 0118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AC stimulation (1.5 milliampere,1.5 Hertz frequency)</intervention_name>
    <arm_group_label>AC: Alternating current</arm_group_label>
    <other_name>DC Stimulator Plus (neuroConn, Germany), serial 0118</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Exclusion Criteria:

          -  Self-reported major psychiatric condition

          -  Screening specific for electrical stimulation (psychotropic medication, metal implants
             in head, epilepsy or seizure history)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2016</study_first_submitted>
  <study_first_submitted_qc>March 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2016</study_first_posted>
  <results_first_submitted>October 26, 2016</results_first_submitted>
  <results_first_submitted_qc>May 13, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 14, 2017</results_first_posted>
  <last_update_submitted>May 13, 2017</last_update_submitted>
  <last_update_submitted_qc>May 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel Aviv University</investigator_affiliation>
    <investigator_full_name>Yair Bar-Haim</investigator_full_name>
    <investigator_title>Professor of Psychology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychophysiologic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sham</title>
          <description>Sham electrical stimulation
Sham stimulation (1.5 milliampere,30 seconds)</description>
        </group>
        <group group_id="P2">
          <title>DC (Direct Current)</title>
          <description>Direct current electrical stimulation
DC stimulation (1.5 milliampere, 20 minutes)</description>
        </group>
        <group group_id="P3">
          <title>AC (Alternating Current)</title>
          <description>Alternating current electrical stimulation
AC stimulation (1.5 milliampere,1.5 Hertz frequency)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sham</title>
          <description>Sham electrical stimulation
Sham stimulation (1.5 milliampere,30 seconds)</description>
        </group>
        <group group_id="B2">
          <title>DC: Direct Current</title>
          <description>Direct current electrical stimulation
DC stimulation (1.5 milliampere, 20 minutes)</description>
        </group>
        <group group_id="B3">
          <title>AC: Alternating Current</title>
          <description>Alternating current electrical stimulation
AC stimulation (1.5 milliampere,1.5 Hertz frequency)</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27" spread="7"/>
                    <measurement group_id="B2" value="23" spread="3"/>
                    <measurement group_id="B3" value="25" spread="5"/>
                    <measurement group_id="B4" value="25" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Galvanic Skin Response (GSR)</title>
        <description>GSR was measured throughout the task using 2 standard electrodes on the fingers. Measurement units were in micro-Siemens; scores were square-root-transformed (a common method in GSR studies). A higher level of GSR in response to stimuli is taken to reflect greater physiological fear response, and thus worse in the context of the relevance of the study conditions to the treatment of anxiety disorders.
Scores were collected in response to presentation of the CS+ (the stimulus conditioned to be associated with an aversive outcome) and the CS- (the stimulus not conditioned to be associated with any outcome).</description>
        <time_frame>During three-day experimental task</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham</title>
            <description>Sham electrical stimulation
Sham stimulation (1.5 milliampere,30 seconds)</description>
          </group>
          <group group_id="O2">
            <title>DC: Direct Current</title>
            <description>Direct current electrical stimulation
DC stimulation (1.5 milliampere, 20 minutes)</description>
          </group>
          <group group_id="O3">
            <title>AC: Alternating Current</title>
            <description>Alternating current electrical stimulation
AC stimulation (1.5 milliampere,1.5 Hertz frequency)</description>
          </group>
        </group_list>
        <measure>
          <title>Galvanic Skin Response (GSR)</title>
          <description>GSR was measured throughout the task using 2 standard electrodes on the fingers. Measurement units were in micro-Siemens; scores were square-root-transformed (a common method in GSR studies). A higher level of GSR in response to stimuli is taken to reflect greater physiological fear response, and thus worse in the context of the relevance of the study conditions to the treatment of anxiety disorders.
Scores were collected in response to presentation of the CS+ (the stimulus conditioned to be associated with an aversive outcome) and the CS- (the stimulus not conditioned to be associated with any outcome).</description>
          <units>micro-Siemens</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CS (conditioned stimulus)+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".45" spread=".38"/>
                    <measurement group_id="O2" value=".56" spread=".57"/>
                    <measurement group_id="O3" value=".65" spread=".46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS-</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".23" spread=".25"/>
                    <measurement group_id="O2" value=".54" spread=".54"/>
                    <measurement group_id="O3" value=".24" spread=".38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Self-reported Fear Rankings</title>
        <description>Participants marked how fearful they are of stimuli used in the task on a single 10-point scale (1=not afraid, 10=extremely afraid). Higher scores therefore reflect greater fear and are worse in the context of treatment for anxiety disorders.
Scores were collected in response to presentation of the CS+ (the stimulus conditioned to be associated with an aversive outcome) and the CS- (the stimulus not conditioned to be associated with any outcome).</description>
        <time_frame>During three-day experimental task</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham</title>
            <description>Sham electrical stimulation
Sham stimulation (1.5 milliampere,30 seconds)</description>
          </group>
          <group group_id="O2">
            <title>DC: Direct Current</title>
            <description>Direct current electrical stimulation
DC stimulation (1.5 milliampere, 20 minutes)</description>
          </group>
          <group group_id="O3">
            <title>AC: Alternating Current</title>
            <description>Alternating current electrical stimulation
AC stimulation (1.5 milliampere,1.5 Hertz frequency)</description>
          </group>
        </group_list>
        <measure>
          <title>Self-reported Fear Rankings</title>
          <description>Participants marked how fearful they are of stimuli used in the task on a single 10-point scale (1=not afraid, 10=extremely afraid). Higher scores therefore reflect greater fear and are worse in the context of treatment for anxiety disorders.
Scores were collected in response to presentation of the CS+ (the stimulus conditioned to be associated with an aversive outcome) and the CS- (the stimulus not conditioned to be associated with any outcome).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CS+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="2.5"/>
                    <measurement group_id="O2" value="4.7" spread="2.1"/>
                    <measurement group_id="O3" value="5.3" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS-</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.0"/>
                    <measurement group_id="O2" value="2.5" spread="1.2"/>
                    <measurement group_id="O3" value="2.7" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sham</title>
          <description>Sham electrical stimulation
Sham stimulation (1.5 milliampere,30 seconds)</description>
        </group>
        <group group_id="E2">
          <title>DC: Direct Current</title>
          <description>Direct current electrical stimulation
DC stimulation (1.5 milliampere, 20 minutes)</description>
        </group>
        <group group_id="E3">
          <title>AC: Alternating Current</title>
          <description>Alternating current electrical stimulation
AC stimulation (1.5 milliampere,1.5 Hertz frequency)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Yair Bar-Haim</name_or_title>
      <organization>Tel Aviv University</organization>
      <phone>97236406393</phone>
      <email>yair1@post.tau.ac.il</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

